The 5 best EDC systems for PMCF under EU MDR in 2026

November 18, 2026 ░░░░░░

A post-market clinical follow-up (PMCF) program never ends. Under the EU Medical Device Regulation (MDR), Annex XIV Part B requires manufacturers to keep collecting clinical data on a device for as long as it stays on the market, and that data has to flow back into the clinical evaluation every cycle.

So the electronic data capture (EDC) system behind a PMCF plan is going to get used for years, across surveys, registries and the occasional full investigation. One study's tool becomes a decade's evidence system.

Most EDC buyer's guides rank vendors on what a Phase III drug trial needs, but PMCF is different. So we're going to discuss the criteria so you can know why we ranked the vendor list the way we did.

What a PMCF study asks of an EDC system

These are the six criteria that separate an EDC that can support a PMCF program from one built for a single study.

1. One system for PMCF surveys and PMCF investigations

MDCG 2020-6 ranks clinical evidence in a hierarchy, and a well-designed survey sits much higher on that ladder than a loose questionnaire. Notified bodies have pushed manufacturers toward the higher-quality end for several years now.

Surveys also have a boundary. Once a PMCF activity adds invasive or burdensome procedures, Article 74 treats it as a PMCF investigation, with notification to member states at least 30 days before it starts. A program can cross that line partway through a device's life, which is why the boundary between a PMCF survey and a clinical investigation makes a difference for software choice. An EDC that handles only surveys forces a migration at the worst possible moment.

2. Device data captured the way ISO 14155 expects

Device studies track different things than drug studies: device deficiencies, lot and serial numbers, implant and explant events, and device-related serious adverse events. ISO 14155:2020 defines how those get recorded, including device deficiencies that could have led to a serious adverse event.

A pharma-built eCRF may be able to bend to fit. But each bend is one more custom build that somebody on the team has to validate before the first patient is enrolled.

3. Direct reach to clinicians and patients

PMCF data often comes from people outside a formal trial site. A surgeon fills out a case series form between procedures, and a patient answers a quality-of-life questionnaire from a phone at home.

Look for electronic patient-reported outcomes (ePRO) without an app install, identifiable responses where the PMCF plan requires them, and translations for every EU market the device is sold in.

4. Traceability from the PMCF plan to the PMCF report

MDCG 2020-7 gives the template for the PMCF plan and MDCG 2020-8 gives the matching template for the PMCF evaluation report. The report mirrors the plan section by section, and its conclusions feed the clinical evaluation report, risk management file and periodic safety update report.

An EDC export that has to be reshaped by hand before anyone can write that report adds weeks to every cycle. Ask vendors to show an export from finished studies.

5. A clear owner for validation

Somebody has to validate the system. A pre-validated platform gives the manufacturer a validation package to review, while a self-hosted tool hands over the whole job.

Add GDPR for EU patient data and 21 CFR Part 11 if any of the data will support an FDA filing.

6. Pricing that works for a whole portfolio

A company with 40 devices on the EU market may run dozens of PMCF activities at once. Per-user, per-site and per-study pricing produce very different bills at that volume, so price the portfolio, not the first study.

BONUS RESOURCE: Click here to download the free guide to selecting the ideal PMCF activity for your PMCF plan.

The 5 best EDC systems for PMCF

The ranking below weighs the six criteria above, with the most weight on criteria 1, 2 and 4, since those decide whether a PMCF report will survive scrutiny from a notified body.

1. Greenlight Guru Clinical

Greenlight Guru Clinical, formerly SMART-TRIAL, was built for medical device and diagnostics studies from the start. It comes pre-validated for ISO 14155 and runs PMCF surveys and full clinical investigations on one platform, which covers criterion 1 without requiring any add-ons.

The eCRF builder comes with 17 pre-validated question types, and the platform supports more than 40 languages. Its ePRO module sends surveys straight to patients, and its case series reporting lets named clinicians submit data, which makes a difference when a PMCF plan calls for identifiable expert input instead of anonymous responses. Device-related adverse events and device deficiencies have a dedicated reporting module tied to the eCRF.

Greenlight Guru reports study setup in two to three weeks and more than 500 medtech clinical trials run on the platform.

Where it fits less well: a large manufacturer whose premarket investigations, drug-device combination programs and imaging reads already live on a pharma enterprise suite may prefer to keep PMCF in that same system. The full EDC systems guide for medical device manufacturers covers that trade-off in more depth.

2. Climedo

Climedo, a Munich-based company, sells EDC alongside eCOA and ePRO modules and has aimed squarely at EU MDR clinical data since before the regulation's May 2021 date of application. Its eSurvey feature has been used to build PMCF surveys, including a mask survey built with consultancy QTEC group.

The company also published a PMCF cost calculator comparing EDC with paper and Excel, which says a lot about its target buyer. In a 2020 Climedo survey of 101 European companies, just 11% had an EDC system in place and more than two-thirds still ran on spreadsheets.

Pricing is a point in its favor for portfolios. One customer, speaking at a Climedo webinar, said the company charges per study or survey instead of per user.

Much of Climedo's published research and case material comes from German-speaking markets. Teams outside that region should ask for references in their own markets, plus the validation documentation for any study that might cross into Article 74 territory.

3. OpenClinica

OpenClinica comes in two very different forms. The Community Edition is open source under the LGPL license and free to download, but the company offers no support for it and the user carries all implementation, integration and validation work.

The commercial edition adds the study designer, hosting, validation support and Participate, an ePRO module that runs in a browser on any device with no app to install. For PMCF patient surveys, Participate is the reason to look at OpenClinica at all.

OpenClinica says on its own comparison page: the combined cost of self-hosting, validating and supporting the free edition can exceed the cost of its software-as-a-service product. For a PMCF program, the commercial edition is the realistic choice.

Device deficiency forms and other device-specific structures have to be designed by the study team, so budget build time against criterion 2.

4. Medidata Rave EDC

Medidata, a Dassault Systèmes company since 2019, runs one of the most widely used EDC platforms in clinical research. Rave EDC connects to eCOA, eConsent, imaging and myMedidata, a patient portal for at-home data capture.

Sensor Cloud, launched in 2021, pulls continuous data from medical-grade sensors and wearables into Rave. For a connected device whose PMCF plan relies on real-world performance data, that capability is hard to match.

Medidata has said that more than 160 medtech sponsors used its platform as of 2020.

The fit problem is complexity. Rave was built around drug development from Phase I to Phase IV, and a 300-respondent survey for a Class IIa instrument rarely needs that much machinery or that much cost.

5. REDCap

REDCap shows up in PMCF programs whether a manufacturer chooses it or not. Vanderbilt University created it in 2004, and it now runs at thousands of academic institutions that license it free through the REDCap Consortium.

The catch is the license. Vanderbilt issues licenses only to nonprofit organizations, and a for-profit company cannot hold one or self-host. A manufacturer cannot run its own PMCF study on REDCap.

What a manufacturer can do is draw on it. Registries are a recognized PMCF activity in MDCG 2020-7, and many academic registries and investigator-initiated studies collect their data in REDCap. A commercial version, REDCap Cloud, is sold separately by nPhase and sits outside the consortium.

So REDCap belongs on this list as a data source to plan around. When a PMCF plan cites a registry, confirm early what export format and data-sharing agreement the hosting institution allows.

BONUS RESOURCE: Click here to watch the free webinar on alternatives to PMCF clinical investigations and how to meet EU MDR PMCF requirements with other clinical data.

How the five compare against the PMCF criteria

Criterion Greenlight Guru Clinical Climedo OpenClinica Medidata Rave REDCap
PMCF surveys and investigations in one system Yes, pre-validated for ISO 14155 Yes, confirm validation scope Commercial edition Yes Nonprofit sites only
Device-specific data structures Native Configurable Custom build Configurable Custom build
Direct patient reach (ePRO) Built in Built in Participate module myMedidata Built-in surveys
Validation burden on manufacturer Low Low to medium High on Community Edition Low to medium Held by host institution
Best fit Device-focused PMCF portfolios EU-focused survey programs Teams with in-house data management Large manufacturers already on Rave Registry data from academic partners

Picking the system for the PMCF plan already on the desk

Start from the plan, not the vendor list. If the PMCF plan leans on surveys today but the device has a known evidence gap that might need an investigation later, criterion 1 outweighs the other elements.

If the plan depends on registries, map which institutions host them and on which platform before signing anything. And if the portfolio runs past 10 devices, price the whole program on paper first, using the per-study versus per-user math from criterion 6.

The MDCG guidance documents on clinical evaluation and PMCF give the structure that every PMCF report gets judged against. Whichever EDC wins the shortlist, run one completed study's export against the MDCG 2020-8 template during the trial period, because that report is what the notified body reads.

Keep reading

If you are building out your PMCF program, these related guides go deeper on the specific pieces:

For a deeper look at how PMCF fits into the wider post-market obligations under MDR, the guide to post-market clinical follow-up activities walks through each method in turn.

Greenlight Guru is the leading cloud-based platform purpose-built for MedTech companies. The end-to-end solution streamlines product development, quality management, and clinical data management by integrating cross-functional teams, processes, and data throughout the entire product lifecycle. Greenlight Guru’s...

BONUS RESOURCE: 15-in-1 Clinical Investigations Content Bundle
Download now
15-in-1 clinical investigations content bundle (new)
Search Results for:
    Load More Results